Articles related to BIOMARKERS

Changes to blood-based biomarkers can be detected before Alzheimer’s symptoms appear, potentially allowing for earlier intervention and more targeted treatment approaches.

The study found no evidence that any of 25 routine clinical laboratory values provide a reliable biomarker of prior infection, PASC, or specific PASC clusters.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

This pivotal research reveals that aMCI patients’ struggle with processing complex sentences could serve as an early indicator of Alzheimer’s, emphasizing the critical need for healthcare professionals to consider language proficiency in early diagnostic evaluations.

Explore the intersection of dietary intervention and biological aging: a fasting-mimicking diet presents a promising avenue for reducing age-related biomarkers and improving metabolic health, offering new strategies in disease prevention and patient care.